Search Results1-9 of  9

  • Steg Philippe Gabriel ID: 9000010291084

    Articles in CiNii:1

    • イベント発症抑制のためにはアテローム血栓症を全身性の血管疾患と捉え,抗血小板療法などで積極的に介入する必要あり (カレント・フォーラム ACC.06 55th Annual Scientific Session) (2006)
  • Steg Philippe Gabriel ID: 9000016558714

    Articles in CiNii:1

    • 座談会 DES時代におけるステント血栓症に関する長期的視点での抗血栓療法〔含 英文〕 (2006)
  • Steg Philippe Gabriel ID: 9000018877276

    Articles in CiNii:1

    • ROUND TABLE DISCUSSION : Current status of ATIS : Regional variation in the treatment (2011)
  • Steg Philippe Gabriel ID: 9000287359619

    Articles in CiNii:1

    • PROFESSIONAL INTERVIEW : Is a paradigm shift in antithrombotic drugs taking place? (2015)
  • STEG P. Gabriel ID: 9000006429261

    Departement de Cardiologie, Hopital Bichat-Claude Bernard (2007 from CiNii)

    Articles in CiNii:1

    • Prevalence, Awareness and Treatment of Cardiovascular Risk Factors in Patients at High Risk of Atherothrombosis in Japan : Results From Domestic Baseline Data of the REduction of Atherotherombosis for Continued Health (REACH) Registry (2007)
  • Steg Philippe Gabriel ID: 9000321626661

    French Alliance for Cardiovascular clinical Trials (FACT), and Université Paris-Diderot, INSERM U-1148, Bichat Hospital, Fibrosis, Inflammation and Remodeling (FIRE) Department, Assistance Publique-Hôpitaux de Paris|National Heart and Lung Institute, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, Imperial College (2016 from CiNii)

    Articles in CiNii:1

    • Future of the Prevention and Treatment of Coronary Artery Disease (2016)
  • Steg Gabriel ID: 9000003882871

    Faculte X. Bichat and Cardiology Department (1998 from CiNii)

    Articles in CiNii:1

    • IS031 Arterial gene transfer. Methods and application to the treatment of coronary artery disease (1998)
  • Steg Ph Gabriel ID: 9000397829243

    Articles in CiNii:1

    • Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials (2018)
  • Steg Ph. Gabriel ID: 9000404634949

    Articles in CiNii:1

    • Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial (2019)
Page Top